vs
Side-by-side financial comparison of Axil Brands, Inc. (AXIL) and Tonix Pharmaceuticals Holding Corp. (TNXP). Click either name above to swap in a different company.
Axil Brands, Inc. is the larger business by last-quarter revenue ($8.1M vs $5.4M, roughly 1.5× Tonix Pharmaceuticals Holding Corp.). Axil Brands, Inc. runs the higher net margin — 8.7% vs -870.3%, a 879.0% gap on every dollar of revenue. On growth, Tonix Pharmaceuticals Holding Corp. posted the faster year-over-year revenue change (108.8% vs 5.2%). Axil Brands, Inc. produced more free cash flow last quarter ($906.4K vs $-41.5M). Over the past eight quarters, Tonix Pharmaceuticals Holding Corp.'s revenue compounded faster (47.4% CAGR vs 12.1%).
Axil Brands, Inc. is a U.S.-headquartered company that designs, manufactures and markets premium hearing protection products, audio enhancement devices and personal audio accessories. Its offerings include custom-fit earplugs, Bluetooth-enabled hearing buds for work, sports and leisure use, serving both consumer and professional segments across global markets.
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
AXIL vs TNXP — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $5.4M |
| Net Profit | $704.9K | $-46.9M |
| Gross Margin | 68.1% | 80.4% |
| Operating Margin | 11.1% | -895.8% |
| Net Margin | 8.7% | -870.3% |
| Revenue YoY | 5.2% | 108.8% |
| Net Profit YoY | 11.2% | -112.2% |
| EPS (diluted) | $0.09 | $-4.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.1M | $5.4M | ||
| Q3 25 | $6.9M | $3.3M | ||
| Q2 25 | $5.8M | $2.0M | ||
| Q1 25 | $6.9M | $2.4M | ||
| Q4 24 | $7.7M | $2.6M | ||
| Q3 24 | $5.9M | $2.8M | ||
| Q2 24 | $6.5M | $2.2M | ||
| Q1 24 | $6.5M | $2.5M |
| Q4 25 | $704.9K | $-46.9M | ||
| Q3 25 | $334.3K | $-32.0M | ||
| Q2 25 | $-245.6K | $-28.3M | ||
| Q1 25 | $576.7K | $-16.8M | ||
| Q4 24 | $633.7K | $-22.1M | ||
| Q3 24 | $-109.8K | $-14.2M | ||
| Q2 24 | $49.5K | $-78.8M | ||
| Q1 24 | $781.1K | $-14.9M |
| Q4 25 | 68.1% | 80.4% | ||
| Q3 25 | 67.6% | 58.4% | ||
| Q2 25 | 70.0% | -63.8% | ||
| Q1 25 | 71.7% | 61.2% | ||
| Q4 24 | 71.1% | 54.2% | ||
| Q3 24 | 71.0% | 44.9% | ||
| Q2 24 | 71.5% | -52.5% | ||
| Q1 24 | 71.5% | 33.1% |
| Q4 25 | 11.1% | -895.8% | ||
| Q3 25 | 6.0% | -1005.1% | ||
| Q2 25 | 0.8% | -1416.2% | ||
| Q1 25 | 8.4% | -660.9% | ||
| Q4 24 | 8.7% | -870.6% | ||
| Q3 24 | -2.4% | -551.2% | ||
| Q2 24 | 2.6% | -3501.6% | ||
| Q1 24 | -1.6% | -860.2% |
| Q4 25 | 8.7% | -870.3% | ||
| Q3 25 | 4.9% | -972.9% | ||
| Q2 25 | -4.3% | -1415.0% | ||
| Q1 25 | 8.3% | -692.8% | ||
| Q4 24 | 8.2% | -856.2% | ||
| Q3 24 | -1.9% | -503.6% | ||
| Q2 24 | 0.8% | -3567.8% | ||
| Q1 24 | 12.1% | -601.9% |
| Q4 25 | $0.09 | $-4.28 | ||
| Q3 25 | $0.04 | $-3.59 | ||
| Q2 25 | $-0.03 | $-3.86 | ||
| Q1 25 | $0.07 | $-2.84 | ||
| Q4 24 | $0.08 | $2302.65 | ||
| Q3 24 | $-0.02 | $-22.68 | ||
| Q2 24 | $0.11 | $-1920.85 | ||
| Q1 24 | $0.04 | $-535.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.0M | $207.6M |
| Total DebtLower is stronger | $138.3K | — |
| Stockholders' EquityBook value | $11.1M | $245.2M |
| Total Assets | $16.2M | $277.2M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.0M | $207.6M | ||
| Q3 25 | $4.1M | $190.1M | ||
| Q2 25 | $4.8M | $125.3M | ||
| Q1 25 | $4.7M | $131.7M | ||
| Q4 24 | $5.2M | $98.8M | ||
| Q3 24 | $4.1M | $28.2M | ||
| Q2 24 | $3.3M | $4.2M | ||
| Q1 24 | $4.9M | $7.0M |
| Q4 25 | $138.3K | — | ||
| Q3 25 | $139.2K | — | ||
| Q2 25 | $140.2K | — | ||
| Q1 25 | $141.0K | — | ||
| Q4 24 | $143.3K | $8.7M | ||
| Q3 24 | $144.3K | $9.4M | ||
| Q2 24 | $146.6K | $10.1M | ||
| Q1 24 | — | $10.8M |
| Q4 25 | $11.1M | $245.2M | ||
| Q3 25 | $10.2M | $231.1M | ||
| Q2 25 | $9.7M | $168.0M | ||
| Q1 25 | $9.7M | $180.4M | ||
| Q4 24 | $8.8M | $139.6M | ||
| Q3 24 | $7.9M | $74.2M | ||
| Q2 24 | $7.7M | $42.1M | ||
| Q1 24 | $8.8M | $108.1M |
| Q4 25 | $16.2M | $277.2M | ||
| Q3 25 | $15.4M | $252.4M | ||
| Q2 25 | $12.9M | $187.4M | ||
| Q1 25 | $13.0M | $192.9M | ||
| Q4 24 | $13.7M | $162.9M | ||
| Q3 24 | $11.4M | $95.0M | ||
| Q2 24 | $11.0M | $70.3M | ||
| Q1 24 | $12.7M | $135.3M |
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.02× | 0.06× | ||
| Q3 24 | 0.02× | 0.13× | ||
| Q2 24 | 0.02× | 0.24× | ||
| Q1 24 | — | 0.10× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $934.8K | $-39.6M |
| Free Cash FlowOCF − Capex | $906.4K | $-41.5M |
| FCF MarginFCF / Revenue | 11.1% | -770.4% |
| Capex IntensityCapex / Revenue | 0.3% | 34.8% |
| Cash ConversionOCF / Net Profit | 1.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-103.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $934.8K | $-39.6M | ||
| Q3 25 | $-739.2K | $-28.8M | ||
| Q2 25 | $194.4K | $-14.8M | ||
| Q1 25 | $-169.9K | $-16.6M | ||
| Q4 24 | $1.0M | $-14.6M | ||
| Q3 24 | $897.3K | $-18.8M | ||
| Q2 24 | $-336.6K | $-9.9M | ||
| Q1 24 | $-912.8K | $-17.6M |
| Q4 25 | $906.4K | $-41.5M | ||
| Q3 25 | $-747.6K | $-29.7M | ||
| Q2 25 | — | $-15.4M | ||
| Q1 25 | $-258.2K | $-16.6M | ||
| Q4 24 | $941.1K | $-14.6M | ||
| Q3 24 | — | $-18.8M | ||
| Q2 24 | $-394.9K | — | ||
| Q1 24 | $-922.1K | $-17.7M |
| Q4 25 | 11.1% | -770.4% | ||
| Q3 25 | -10.9% | -904.1% | ||
| Q2 25 | — | -768.8% | ||
| Q1 25 | -3.7% | -682.8% | ||
| Q4 24 | 12.2% | -566.7% | ||
| Q3 24 | — | -666.5% | ||
| Q2 24 | -6.1% | — | ||
| Q1 24 | -14.3% | -712.4% |
| Q4 25 | 0.3% | 34.8% | ||
| Q3 25 | 0.1% | 29.2% | ||
| Q2 25 | — | 26.4% | ||
| Q1 25 | 1.3% | 0.2% | ||
| Q4 24 | 0.9% | 0.1% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | 0.9% | 0.0% | ||
| Q1 24 | 0.1% | 4.4% |
| Q4 25 | 1.33× | — | ||
| Q3 25 | -2.21× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.29× | — | ||
| Q4 24 | 1.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.80× | — | ||
| Q1 24 | -1.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
TNXP
| Zembrace Symtouch | $3.1M | 58% |
| Other | $2.3M | 42% |
